Shubham Agarwal

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Cardiovascular Disease

Antiplatelet Therapy

Top Venues

Current diabetes reports

Cardiovascular drugs and therapy

Postgraduate medical journal

Nature reviews. Endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Shubham Agarwal, Rodolfo J Galindo, Amy V Shah, Marconi Abreu
Diabetes Technology in People with Type 2 Diabetes: Novel Indications. Current diabetes reports 24 (5) (2024)
Shubham Agarwal, Rodolfo J Galindo, Amy V Shah, Marconi Abreu
Diabetes Technology in People with Type 2 Diabetes: Novel Indications. Current diabetes reports 24 (5) (2024)
Shubham Agarwal, Rodolfo J Galindo, Amy V Shah, Marconi Abreu
Diabetes Technology in People with Type 2 Diabetes: Novel Indications. Current diabetes reports (2024)
Shubham Agarwal, Rodolfo J Galindo, Amy V Shah, Marconi Abreu
Diabetes Technology in People with Type 2 Diabetes: Novel Indications. Current diabetes reports 24 (5) (2024)
Shubham Agarwal, Rodolfo J Galindo, Amy V Shah, Marconi Abreu
Diabetes Technology in People with Type 2 Diabetes: Novel Indications. Current diabetes reports 24 (5) (2024)
Shubham Agarwal, Ildiko Lingvay
SGLT inhibitors: a serendipitous glycaemic tale. Nature reviews. Endocrinology (2023)
Shubham Agarwal, Sanjeev Kumar Agarwal
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications. Cardiovascular drugs and therapy 35 (3) (2020)
Shubham Agarwal, Sanjeev Kumar Agarwal
Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV. Postgraduate medical journal 96 (1137) (2020)